Zura Bio (ZURA) Interest Coverage Ratio Growth (1y) (2023 - 2026)
Zura Bio (ZURA) Interest Coverage Ratio Growth (1y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,132.22 Bn | 67,131.94 Bn | - | -60.44% |
| 2 | Nanobiotix | 1,910.87 Bn | 1,910.81 Bn | - | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - | -347.04% |
| 4 | BeOne Medicines | 471.60 Bn | 466.80 Bn | 1.35 Bn | 787.12% |
| 5 | Vertex Pharmaceuticals | 121.71 Bn | 114.46 Bn | 2.59 Bn | 53.59% |
| 6 | Regeneron Pharmaceuticals | 69.83 Bn | 61.07 Bn | 3.31 Bn | -32.04% |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - | - |
| 8 | Argenx Se | 55.83 Bn | 50.65 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.33 Bn | 34.32 Bn | 959.66 Mn | 1,378.45% |
| 10 | Zura Bio | 611.61 Mn | 611.61 Mn | - | 33.78% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33.78% |
| Dec 31, 2025 | -17.03% |
| Sep 30, 2025 | 42.41% |
| Jun 30, 2025 | 37.02% |
| Mar 31, 2025 | -129.79% |
| Dec 31, 2024 | -35.13% |
| Sep 30, 2024 | 86.69% |
| Mar 31, 2024 | 90.23% |
| Dec 31, 2023 | -4,207.68% |
| Sep 30, 2023 | -8,007.63% |